Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain.
NCT00314652
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
260
Enrollment
INDUSTRY
Sponsor class
Conditions
Osteoarthritis
Interventions
DRUG:
Buprenorphine transdermal delivery system
Sponsor
Purdue Pharma LP